LEMAITRE VASCULAR INC (LMAT)

US5255582018 - Common Stock

74.22  +7.45 (+11.16%)

After market: 72.75 -1.47 (-1.98%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

LEMAITRE VASCULAR INC

NASDAQ:LMAT (5/3/2024, 7:03:45 PM)

After market: 72.75 -1.47 (-1.98%)

74.22

+7.45 (+11.16%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap1.67B
Shares
PE55.39
Fwd PE44.03
Dividend Yield0.96%
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

LMAT Daily chart

Company Profile

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company is headquartered in Burlington, Massachusetts and currently employs 591 full-time employees. The company went IPO on 2006-10-19. The firm develops, manufactures and markets vascular devices to address the needs of vascular surgeons, and to a lesser degree, other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. The Company’s product offerings are sold globally, primarily in the United States, Europe, Canada and Asia Pacific. Its products and services include Allografts, Angioscopes, Balloon Catheters for Embolectomy and Thrombectomy, Balloon Catheters for Occlusion and Perfusion, Bovine Grafts, Vascular and Cardiac Patches, Carotid Shunts, Closure Systems, Ovine Vascular Grafts, Polyester Vascular Grafts, ePTFE Vascular Grafts Radiopaque Tape, and Valvulotomes. Its PeriVu Disposable Angioscope is a fiberoptic catheter used for viewing the lumen of a blood vessel.

Company Info

LEMAITRE VASCULAR INC

63 2nd Ave

Burlington MASSACHUSETTS 01803

P: 17812212266

CEO: George W. LeMaitre

Employees: 591

Website: https://www.lemaitre.com/

LMAT News

News Image3 days ago - InvestorPlaceLMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024

LMAT stock results show that LeMaitre Vascular beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

News Image3 days ago - BusinessInsiderLMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips LeMaitre Vascular (NASDAQ:LMAT) just reported results for the first quarter of ...

News Image3 days ago - LeMaitre Vascular, Inc.LeMaitre Q1 2024 Financial Results

BURLINGTON, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2024...

News Image5 days ago - Investor's Business DailyInspire Medical Systems Stock Sees IBD RS Rating Rise To 78

On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.

News Image16 days ago - LeMaitre Vascular, Inc.LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024

BURLINGTON, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2024...

News Imagea month ago - LeMaitre Vascular, Inc.LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference

BURLINGTON, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer,...

LMAT Twits

Here you can normally see the latest stock twits on LMAT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example